Schneider, B. P., Gray, R. J., Radovich, M., Shen, F., Vance, G., Li, L., . . . Badve, S. S. (2013). Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Stile di citazione ChicagoSchneider, Bryan P., et al. Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated With Paclitaxel With and Without Bevacizumab; Results From ECOG 2100 Trial. 2013.
Citazione MLASchneider, Bryan P., et al. Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated With Paclitaxel With and Without Bevacizumab; Results From ECOG 2100 Trial. 2013.